U.S. Infection Imaging Services Market Size, Share & Trends Report

U.S. Infection Imaging Services Market Size, Share & Trends Analysis Report By Indication (Osteomyelitis, Acute Appendicitis, CAD, Colitis, Pneumonia, Tuberculosis), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-989-6
  • Number of Pages: 102
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Indication
                        1.1.2. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1: Understanding the market dynamics
                        1.9.2. Objective 2: Understanding the market estimates and forecasts
                        1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
                        1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Infection Imaging Services Market Variables, Trends & Scope
                    3.1. Market Lineage outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Product Pipeline Analysis, by Stage
                    3.4. Market Dynamics
                        3.4.1. Market Driver Analysis
                            3.4.1.1. Increasing prevalence of infectious diseases
                            3.4.1.2. Growing number of outpatient settings with imaging services
                            3.4.1.3. Growing awareness about medical imaging
                        3.4.2. Market Restraint Analysis
                            3.4.2.1. Radiation exposure
                    3.5. U.S. Infection Imaging Services : Market Analysis Tools
                        3.5.1. Industry Analysis - Porter’s
                            3.5.1.1. Supplier Power
                            3.5.1.2. Buyer Power
                            3.5.1.3. Substitution Threat
                            3.5.1.4. Threat from new entrant
                            3.5.1.5. Competitive rivalry
                        3.5.2. PESTEL Analysis
                            3.5.2.1. Political Landscape
                            3.5.2.2. Environmental Landscape
                            3.5.2.3. Social Landscape
                            3.5.2.4. Technology Landscape
                            3.5.2.5. Legal Landscape
                        3.5.3. Major Deals & Strategic Alliances Analysis
                        3.5.4. Covid-19 Impact Analysis
Chapter 4. U.S. Infection Imaging Services Market: Segment Analysis, by Indication, 2018 - 2030 (USD Million)
                    4.1. Definitions & Scope
                    4.2. Indication market share analysis, 2021 & 2030
                    4.3. Segment Dashboard
                    4.4. U.S. Infection Imaging Services Market, by indication, 2018 to 2030
                    4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.5.1. Fever of unknown origin
                            4.5.1.1. Nuclear Medicine
                            4.5.1.2. Others
                        4.5.2. Orthopedic Hardware
                            4.5.2.1. Nuclear Medicine
                            4.5.2.2. Others
                        4.5.3. Musculoskeletal infection
                            4.5.3.1. Nuclear Medicine
                            4.5.3.2. Others
                        4.5.4. Acute Appendicitis
                            4.5.4.1. Nuclear Medicine
                            4.5.4.2. Others
                        4.5.5. Osteomyelitis
                            4.5.5.1. Nuclear Medicine
                            4.5.5.2. Others
                        4.5.6. Systemic vasculitis
                            4.5.6.1. Nuclear Medicine
                            4.5.6.2. Others
                        4.5.7. Skin and soft tissue infection
                            4.5.7.1. Nuclear Medicine
                            4.5.7.2. Others
                        4.5.8. Cardiovascular inflammation
                            4.5.8.1. Nuclear Medicine
                            4.5.8.2. Others
                        4.5.9. Pneumonia
                            4.5.9.1. Nuclear Medicine
                            4.5.9.2. Others
                        4.5.10. Tuberculosis
                            4.5.10.1. Nuclear Medicine
                            4.5.10.2. Others
                        4.5.11. Endocarditis
                            4.5.11.1. Nuclear Medicine
                            4.5.11.2. Others
                        4.5.12. Myocarditis
                            4.5.12.1. Nuclear Medicine
                            4.5.12.2. Others
                        4.5.13. LVAD infection
                            4.5.13.1. Nuclear Medicine
                            4.5.13.2. Others
                        4.5.14. Crohn’s disease
                            4.5.14.1. Nuclear Medicine
                            4.5.14.2. Others
                        4.5.15. Colitis
                            4.5.15.1. Nuclear Medicine
                            4.5.15.2. Others
                        4.5.16. Atherosclerosis
                            4.5.16.1. Nuclear Medicine
                            4.5.16.2. Others
                        4.5.17. Coronary artery disease
                            4.5.17.1. Nuclear Medicine
                            4.5.17.2. Others
                        4.5.18. Organ transplant rejection
                            4.5.18.1. Nuclear Medicine
                            4.5.18.2. Others
                        4.5.19. Others
                            4.5.19.1. Nuclear Medicine
                            4.5.19.2. Others
Chapter 5. Others U.S. Infection Imaging Services Market - Competitive Analysis
                    5.1. Key companies profiled
                        5.1.1. Rayus Radiology
                            5.1.1.1. Company Overview
                            5.1.1.2. Financial Performance
                            5.1.1.3. Product Benchmarking
                            5.1.1.4. Strategic Initiatives
                        5.1.2. CMS Diagnostic Services
                            5.1.2.1. Company Overview
                            5.1.2.2. Financial Performance
                            5.1.2.3. Product Benchmarking
                            5.1.2.4. Strategic Initiatives
                        5.1.3. Radnet, Inc
                            5.1.3.1. Company Overview
                            5.1.3.2. Financial Performance
                            5.1.3.3. Product Benchmarking
                            5.1.3.4. Strategic Initiatives
                        5.1.4. Dignity Health
                            5.1.4.1. Company Overview
                            5.1.4.2. Financial Performance
                            5.1.4.3. Product Benchmarking
                            5.1.4.4. Strategic Initiatives
                        5.1.5. Alliance Medical
                            5.1.5.1. Company Overview
                            5.1.5.2. Financial Performance
                            5.1.5.3. Product Benchmarking
                            5.1.5.4. Strategic Initiatives
                        5.1.6. Inhealth Group
                            5.1.6.1. Company Overview
                            5.1.6.2. Financial Performance
                            5.1.6.3. Product Benchmarking
                            5.1.6.4. Strategic Initiatives
                        5.1.7. Sonic Healthcare
                            5.1.7.1. Company Overview
                            5.1.7.2. Financial Performance
                            5.1.7.3. Product Benchmarking
                            5.1.7.4. Strategic Initiatives
                        5.1.8. Medica Group
                            5.1.8.1. Company Overview
                            5.1.8.2. Financial Performance
                            5.1.8.3. Product Benchmarking
                            5.1.8.4. Strategic Initiatives
                        5.1.9. Unilabs
                            5.1.9.1. Company Overview
                            5.1.9.2. Financial Performance
                            5.1.9.3. Product Benchmarking
                            5.1.9.4. Strategic Initiatives
                        5.1.10. Simonmed Imaging
                            5.1.10.1. Company Overview
                            5.1.10.2. Financial Performance
                            5.1.10.3. Product Benchmarking
                            5.1.10.4. Strategic Initiatives


List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Infection Imaging Services Market, By Indication, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. infection imaging services market: Market snapshot
Fig. 9 U.S. infection imaging services market: Market segmentation
Fig. 10 U.S. infection imaging services market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 U.S. infection imaging services market driver impact
Fig. 14 U.S. infection imaging services market restraint impact
Fig. 15 U.S. infection imaging services market porter’s five forces analysis
Fig. 16 U.S. infection imaging services market PESTEL analysis
Fig. 17 U.S. infection imaging services market segment dashboard
Fig. 18 U.S. infection imaging services market: indication movement Analysis
Fig. 19 Fever of unknown origin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Orthopedic hardware market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Musculoskeletal infection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Acute appendicitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Osteomyelitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Systemic vasculitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Skin and soft tissue infection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Cardiovascular inflammation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Pneumonia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Tuberculosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Endocarditis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Myocarditis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 LVAD infection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Crohn’s disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Colitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Atherosclerosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Coronary artery disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Organ transplant rejection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon